Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Invesco NASDAQ 100 ETF (QQQM) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

Invesco NASDAQ 100 ETFTrade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

Invesco NASDAQ 100 ETF vs DENTSPLY SIRONA Inc — how do they compare? Invesco NASDAQ 100 ETF trades at $309.39 (market cap $113.40B), while DENTSPLY SIRONA Inc trades at $8.83 (market cap $1.73B). The key difference: Invesco NASDAQ 100 ETF is far larger — about 65.5× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Invesco NASDAQ 100 ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Invesco NASDAQ 100 ETF for 54 Days and DENTSPLY SIRONA Inc for 72 Days on average.

QQQMXRAY
Market Cap
$113.40B$1.73B
Volume
2,866,2366,198,582
Sector
Broad Market / FactorHealth
52-Week High
$312.76$14.68
52-Week Low
$229.87$8.52
Typical Hold Time
54 Days72 Days
Enterprise Value
—$3.80B
Dividend Yield
—5.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invesco NASDAQ 100 ETF

QQQM trades at $307.85, down 1.33% today, while maintaining a bullish technical outlook with strong moving average support. The Invesco NASDAQ 100 ETF continues to benefit from institutional accumulation, with QRG Capital Management increasing its position by 207.5% in Q2 2026. Technical indicators show the ETF trading near key resistance at $309, with support established at $305 and $303 levels. The fund's 0.15% expense ratio provides a cost advantage over similar NASDAQ-100 tracking products.

QQQM offers efficient exposure to NASDAQ-100 growth stocks with lower fees, though concentration in technology sectors presents volatility risks. Institutional buying signals confidence in the ETF's long-term prospects despite recent market fluctuations. Investors should monitor technology sector performance and interest rate sensitivity as key drivers of future returns.

DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) trades at $8.69, down 1.76% on the day and near a 52-week low, reflecting ongoing operational challenges. The stock shows a bearish technical trend with weak moving averages, while fundamentals reveal declining revenue, negative net income margins, and elevated debt levels. Recent Q2 2026 earnings beat expectations but sales fell 4.1%, indicating persistent headwinds in dental markets.

The outlook remains cautious due to margin pressure and competitive threats, though analyst consensus suggests upside to a $13.40 price target. Key risks include execution of the turnaround plan, macroeconomic sensitivity, and high leverage. Investment appeal hinges on successful restructuring and recovery in core dental segments.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QQQM
95% Buy5% Sell
Avg holding period · 54 Days
XRAY

No sentiment data available yet.

Top news

Latest headlines on both assets

About Invesco NASDAQ 100 ETF

QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.

Read more on QQQM →

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY →